Not surprisingly, opinions concerning what went wrong with the Global Fund’s executive director selection process vary, depending on who you ask. Many of the people we spoke to in preparation for this article – including Board delegations – were reluctant to comment at all, let alone publicly.
You are here
The Global Fund Board has appointed Marijke Wijnroks as Interim Executive Director effective 1 June 2017. The four-year term of the current executive director, Mark Dybul, expires on 31 May. Dr Wijnroks will serve until a new executive director is selected by the Board and is able to begin.
Citing concerns about the process, the Global Fund Board has decided to prolong the search for a new executive director.
The next executive director of the Global Fund will be selected at a Board Retreat that will be held on 27-28 February in Geneva. He or she will replace Dr Mark Dybul, whose term ends on 31 May 2017.
The main steps of the recruitment process, as decided by the Board and as reported by GFO last November, were as follows:
The ED of the Global Fund reports on how the Fund intends to increase programmatic quality and efficiency
In his report to the Board, Executive Director Dr Mark Dybul, highlighted that in order for the Fund to maximize impact at the country level, the Fund must explore ways to improve program quality and efficiency from design to implementation. Dr Dybul stated in the report that the approach it is taking builds upon the Program Quality and Efficiency project it developed in 2015 which aims to improve health program outcomes.
On 16-17 November 2016, the Global Fund Board held its 36th meeting in Montreux, Switzerland. GFO was present, with observer status.
The Board has formally launched the recruitment process for a new executive director to replace Dr Mark Dybul, whose term expires on 31 May 2017. Dr Dybul has indicated that he is not seeking a renewal of his term.
The Board is expected to make a selection of the new E.D. during a Board retreat scheduled for 28 February-1March.
Executive Director of Global Fund highlights efforts to increase impact in the fight against TB and MDR-TB
One of the major themes in the Executive Director’s Report is that multi-drug resistant TB is creating a real threat to global health security and now is the time for a rapid and urgent response on TB. The disease has become a public health crisis as more people die from drug-resistant TB than any other antimicrobial resistant agent.
Le Bureau des circonscriptions africaines du Fonds mondial lance un appel à candidatures pour le poste de Directeur/trice général/e. Le poste est situé à Addis-Abeba, en Ethiopie.
The African Constituency Bureau of the Global Fund is seeking applications for the position of Executive Director. The position is located in Addis Ababa, Ethiopia. The Bureau provides support to the the African constituency representatives to the Global Fund Board – i.e. the Eastern and Southern Africa (ESA) constituency, and the West and Central African (WCA) constituency.